Xiaoling Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Papers in
-
- Lung Cancer Treatments and Mutations 17
- Ferroptosis and cancer prognosis 11
- Prostate Cancer Treatment and Research 7
-
- Head and Neck Cancer Studies 15
- Co-authors
- Guiyuan Li (50 shared papers)Wei Xiong (26 shared papers)Zhaoyang Zeng (25 shared papers)Yong Li (8 shared papers)Yongzhen Mo (6 shared papers)Lianxiang Luo (12 shared papers)Can Jie Guo (7 shared papers)Fang Xiong (7 shared papers)
- Journals
- Molecular Cancer (6 papers)Journal of Biological Chemistry (6 papers)Cancer Letters (4 papers)Journal of Cancer (4 papers)Journal of Experimental & Clinical Cancer Research (3 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xiaoling Li
216 papers receiving 7.7k citations
Xiaoling Li's Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 768
- Otorhinolaryngology 307
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.3k
- Immunology 743
Countries citing papers authored by Xiaoling Li
This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).
Fields of papers citing papers by Xiaoling Li
This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The role of microenvironment in tumor angiogenesis Hit paper breakdown → | 2020 | 587 |
| 2 | Neoantigen vaccine: an emerging tumor immunotherapy Hit paper breakdown → | 2019 | 585 |
| 3 | 2017 | 314 | |
| 4 | Single‐cell RNA sequencing in cancer research Hit paper breakdown → | 2021 | 283 |
| 5 | 2019 | 209 | |
| 6 | 2021 | 178 | |
| 7 | 2018 | 152 | |
| 8 | 2022 | 138 | |
| 9 | 2006 | 134 | |
| 10 | 2017 | 123 | |
| 11 | 2020 | 120 | |
| 12 | Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant Hit paper breakdown → | 2024 | 119 |
| 13 | 2022 | 116 | |
| 14 | 2021 | 111 | |
| 15 | 2008 | 108 | |
| 16 | 2021 | 108 | |
| 17 | 2022 | 103 | |
| 18 | 2017 | 102 | |
| 19 | 2020 | 100 | |
| 20 | 2008 | 97 |
About Xiaoling Li
Xiaoling Li is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Molecular Biology, Immunology and Oncology, having authored 222 papers that have together received 7.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Head and Neck Cancer Studies (15 papers), Ferroptosis and cancer prognosis (11 papers), Cancer Immunotherapy and Biomarkers (8 papers), Nitric Oxide and Endothelin Effects (8 papers), Prostate Cancer Treatment and Research (7 papers), Advanced Drug Delivery Systems (7 papers) and interferon and immune responses (6 papers). The work is most often cited by research in Cancer Research (768 citations), Otorhinolaryngology (307 citations), Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Immunology (743 citations). Xiaoling Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Yong Li, Yongzhen Mo, Lianxiang Luo, Can Jie Guo, Fang Xiong, Qianjin Liao and Xiayu Li. Their work appears in journals such as Molecular Cancer, Journal of Biological Chemistry, Cancer Letters, Journal of Cancer and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.